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WE have reported that spontaneous attacks of periodic
paralysis are preceded by large increases of urinary aldo-
sterone and by intense retention of sodium (Conn et al.
1956). This is followed shortly by sequestration of
potassium within the body, both serum and urinary
potassium falling abruptly and intensely. Serum-sodium
often rises to abnormally high values as serum-potassium
reaches its lowest ones. As the attack subsides a great
diuresis of sodium occurs together with a less intense
increase of urinary potassium. Serum-sodium and serum-
potassium return to normal together. By this time
urinary aldosterone has returned to base-line values.
We have explored further the role of retention of sodium
in setting off potassium sequestration-i.e., acute hypo-
kalsemia and hypokaluria. Two young men with the
familial type of periodic paralysis were the subjects of
this study. One of them, living in our laboratory, sub-
mitted cheerfully to 11 months of a rigid metabolic
balance regime. The other was studied for 30 days to
test in a different person the applicability of the meta-
bolic principles discovered in the first one. The subjects
are not related.
Fig. I-Induction of episode of periodic paralysis by 2-methyl-9-cx-fluorohydrocortisone
and high sodium intake.
The aim of this short communication is to disseminate
quickly information which is of immediate practical
value to patients with this disorder. Extensive data will
be published later. At this time we wish merely to outline
some of our results and conclusions.
Fig. 2-Changes in electrolyte metabolism during episode of periodic
paralysis induced by administration of glucose and insulin.
Method
Two levels of sodium intake were used-
8 and 208 m.eq. per day. The composition
of the daily ration was otherwise the same,
the high sodium regime differing from
the low by addition of sodium chloride
to the basic diet. Chloride ion, the only
other variable, was 27 m.eq. per day on
the low, and 229 m.eq. per day on the
high, sodium ration. Potassium intake
was constant at 132 m.eq. per day.
Results
Under both of these dietary conditions
a series of identical experiments were
carried out, each designed to induce an
episode of periodic paralysis. The follow-
ing facts were disclosed :
(1) When the diet contained the larger
quantity of sodium the administration of
glucose and insulin,, or of 2-methyl-9-a-
fluorohydrocortisone (an extremely potent
mineralocorticoid) produced complete (from
the neck down) and prolonged (24-48 hours)
paralysis (figs. 1 and 2).
(2) When glucose and insulin induce an
episode of periodic paralysis the great
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Fig. 3&mdash;Changes in electrolyte metabolism and urinary
excretion of aldosterone during episode of paralysis
induced by glucose and insulin. Lower part of histogram :
first 12 hours ; upper part, second 12 hours. Aldosterone
estimated by method of Neher and Wettstein (1956).
retention of sodium which precedes the actual attack
is accompanied by a sharp rise of urinary aldo-
sterone (fig. 3). During the intense diuresis of sodium
which follows an attack urinary aldosterone falls
below normal. By what means increased utilisation
of carbohydrate produces increased secretion of aldo-
sterone in this disease is now under investigation.
(3) In all of these paralytic episodes urinary and
serum K fell sharply but the sequestration of K was
always preceded and then accompanied by intense
retention of sodium.
(4) The very earliest return of muscle function is
related temporally to increasing amounts of urinary
sodium ; and in some attacks it can be demonstrated
that serum-potassium is still near its minimal value
at the time that the ability to move muscles is return-
ing. This is then followed by a rapid increase of
urinary and serum potassium.
(5) Total body exchangeable sodium (Na22) was
Fig, 4-Data indicating failure of 2-methy-9-&agr;-fluorohydrocortisone to induce attack when
sodium retention is prevented by low-sodium diet.
found to be elevated before induction of
attacks and this increased considerably during
induction of an attack (fig. 1).
(6) When retention of sodium was prevented
by provision of the diet very low in sodium,
attaclc8 of paralY8i8 could not be produced by the
procedures which had provoked the severe
ones previously mentioned ; and sequestra-
tion of potassium did not occur (fig. 4). This
has been demonstrated in both of our cases
of periodic paralysis.
(7) As in normal individuals, these subjects
when taking the low-sodium diet exhibited
persistently raised levels of urinary aldo-
sterone, yet there were no attacks. Thus, the
sudden sequestration of potassium which
accompanies an attack of periodic paralysis is
not due per se to the presence of aldosterone.
Sodium must be available and must be
retained in the body before potassium begins
to move to its site or sites of sequestration.
(8) Whereas 2-methyl-9-a-fluorohydrocorti-
sone produced prolonged retention of sodium
and diuresis of potassium in normal men (fig.
5), it produced sodium retention followed by
sequestration of potassium in both patients
Fig. 5-Effects of 2-methyl-9-a-fluorohydrocortisone
on electrolyte metabolism in two healthy young
men aged 21 (A) and 19 (B).
with periodic paralysis (fig. 1). This would
appear to rule out the possibility of production
of an abnormal potassium-retaining adrenal
steroid in this disease. Instead it appears that
when a sodium-retaining corticoid is actively
causing sodium retention in periodic paralysis
the potassium response is a paradoxical one.
This conclusion is strengthened by the fact
that we have clearly identified as aldosterone
the urinary sodium-retaining corticoid found
in excess in this disorder.
(9) Skeletal muscle obtained during the
period of high-sodium intake contains much
too much sodium and a normal or slightly sub-
normal concentration of potassium (see accom-
panying table). Microscopically, the lesion
characteristic of this disease is observed-
namely, numerous large and small glistening
vacuoles within muscle-fibres. The vacuoles
do not stain as fat or glycogen (fig. 6).
(10) In skeletal muscle obtained after 44
days on the low-sodium diet this vacuolar
change in the muscle-fibres has disappeared
(fig. 6b). The accompanying table shows
the values for concentration of Na and K
in muscle at this time.
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Fig. 6-Skeletal muscle from patient with periodic paralysis : (a)
during high-sodium intake, showing vacuoles ; (b) during low-sodium
intake, showing no vacuoles.
Discussion
The dramatic decrease in the level of serum-potassium
at the beginning of a paralytic episode in the 
" familial
type" of periodic paralysis has resulted iii extensive
studies of potassium metabolism in this disease. Current
therapy consists in administration of potassium salts
daily by mouth as prophylaxis, and of potassium chloride
intravenously for established attacks. We are impressed
with the facts that, although an inripient attack can be
aborted or a severe one sometimes ended by administra-
tion of potassium, they still occur even when 10-12 g.
of potassium chloride is ingested daily.
Studies of sodium metabolism in this disease are
meagre. In two studies sodium balance was found to be
positive before and negative after the attack (Ferrebee
et al. 1940, Danowski et al. 1948), but the significance of
this finding was not appreciated. It is clear from the
present data that the sudden and profound sequestration
of potassium is always preceded by all intense positive
balance for sodium. III normal individuals on very low
levels of dietary sodium, urinary excretion of potassium
SODIUM AND POTASSIUM COKTHXT OF MUSCLE AND SERUM IN
PERIODIC PARALYSIS, HEALTH, AND PRIMARY ALDORTEROX1,nr
is not increased by administration of 2-methyl-9-K-nuo!’o-
hydrocortisone (J. W. Conn, unpublished). Thus, it
appears that even ill normal people the effects of mineralo-
corticoids upon potassium metabolism are secondary to
retention of the sodium ion.
With respect to the clinical entity of periodic paralysis
we call attention to several well-recognised discrepancies
which make it difficult to correlate attacks of paralysis
solely with an abnormality of potassium metabolism :
(1) Attacks of total paralysis may occur at levels of serum-
potassium which when found in other conditions are not low
enough to result in muscular paralysis (Darrow 1946, Danowski
et al. 1949, RIkinton et al. 1951).
(2) The severity of different attacks in the same individual
is not correlated closely with the degree of hypokal&aelig;mia.
(3) When the serum-potassium has been estimated fre-
quently throughout attacks, we have often observed that
muscular function begins to return while serum-potassium
values are close to the lowest value observed during the attack.
(4) Sporadic cases (Watson 1946, Bull et al. 1953) and
families (Tyler et al. 1951, McArdle 1956) exhibit the typical
clinical syndrome without any decrease of serum-potassium
during attacks. It seems very significant that in such cases
Tyler et al. (195 1) have found the vacuolar myopathy (a lesion
characteristic of familial periodic paralysis [Goldflam 1897,
Schmidt 1919, Zabriskie and Franz 1932, Allott and MeArdle
1938]) which is demonstrated in fig. 6a and shown in fig. 6b
to have disappeared with reduction of intracellular sodium
toward normal.
All of these considerations viewed in the light of
the experimental data described here, suggest that the
common denominator is an excessive quantity of intra-
cellular sodium. This by no means excludes hypokal&aelig;mia,
when it occurs. as a contributory factor ; nor does it
mean that a, sudden increase of intracellular potassium
does not influence the onset of a paralytic attack. It
does indicate, however, that retention of sodium is the
primary factor which sets into motion the characteristic
chain of events in an episode of periodic paralysis; and
it provides a much more direct approach to the prevention
of paralytic episodes.
Comparison of the sodium and potassium content of
muscle in periodic paralysis and in primary aldosteronism
(see table) suggests that when intracellular sodium is too
high the muscle cell must be able to extrude potassium if
paralysis is to be avoided. The sum of the intracellular
cations may be a critical factor in the muscular paralysis.
The mechanism by which in most of these cases retention
of sodium under the influence of aldosterone sets off the
potassium-sequestration phenomenon requires further
study. Similarly, the mechanism by which intermittent
aldosteronism exists in this disease is not yet clear.
It seems likely, then, that an abnormally high concen-
tration of sodium within the muscle cell is partly respon-
sible for the disturbance of muscle function in periodic
paralysis. The histological lesion of this disease&mdash;i.e.,
hydropic vacuolisation within the muscle-fibre--is
related to the high concentration of intracellular sodium,
although total cationic concentration may be important.
Since the same pathological lesion has been observed in
patients who, although suffering from typical periodic
paralysis, exhibit no hypokalsemia or hypokaluria during
attacks (Tyler et al. 1951), it is probable that retention of
abnormal amounts of sodium is the common factor in
the various subgroups of periodic paralysis. Balance
studies for sodium are needed in such cases.
. 
From a practical point of view these studies indicate
that a diet low in sodium prevents attacks of periodic
paralysis. A period of- " desalting " with mercurial
diuretics and/or carbonic-anhydrase inhibitors, associated
with a low-sodium diet, may be required as an initialstep.
Apparently the stimulus for excessive secretion of
aldosterone in periodic paralysis is extra-adrenal in origin.
Although adrenalectomy would remove the source of
aldosterone, we believe that this procedure is not indi-
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cated because : (1) episodes of paralysis become less
frequent and nhally disappear as the patient grows
older; and (2) replacement therapy, unless grossly sub-
optimal, would; probably be associated with periodic
retention of sodium, especially under conditions of stress
(Ingle 1952). 
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THE EFFECT OF TOLAZOLINE
HYDROCHLORIDE ON TIC DOULOUREUX
E. W. POOLE
M.B. N.Z., M.R.C.P.E.
LATE NUFFIELD DOMINIONS TRUST ASSISTANT AND GOODGER
SCHOLAR, DEPARTMENT OF NEUROLOGY, UNITED OXFORD
HOSPITALS
IT has long been recognised that attacks of tic doulou-
reux may be suppressed by vasomotor agents such as
choline derivatives, nicotinic acid, histamine, and amyl
nitrite (Cooper 1938, Adams and Robinson 1941, Karl et
al. 1945, Wolff 1948). Such effects, even if temporary,
provide a line of therapeutic investigation and are of
interest in the study both of the disease and of the
pharmacology of the agent used. In this field the action
of more recent and possibly more effective vasodilator
agents appears little explored, and this report presents
some experiences with tolazoline hydrochloride. The
aim has been to determine the existence and character-
istics of any effects rather than to establish an optimal
therapeutic regime.
Material and Methods
Observations were made in 9 patients with tic, 2 of whom
had disseminated sclerosis and 1 an acoustic neuroma. 3 had
had alcohol injection years previously. Only unequivocal
eases of tic were accepted. Patients with frequent daily pains
and active trigger areas but without severe cardiovascular
disease were selected. Most of them were awaiting surgical
treatment, which was delayed only in some instances where
the response seemed especially promising. Tolazoline hydro-
ehtoride (’Priscol,’ Ciba) was usually given first orally
(125 mg.), as a test for idiosyncrasy, and in 1 case this route
"one was used. However, graduated intravenous administra-
tion (up to 50 mg. in 10-15 minutes) was preferred so, that
observations could be made over a short period, thereby
Minimising errors from fluctuations in clinical stato. Peripheral
vascular responses were assessed by subjective flushing and
by objective changes-e.g., conjunctival suffusion and changes
in skin colour and temperature (measured with Marks skin
thermometers on the extremities). The patient was kept
resting flat during intravenous tests, and the blood-pressure
and pulse-rate were noted at intervals.
The effects on the tic were judged by the number of attacks
and their ease of provocation, both with ordinary activity
(talking, eating, &c.) and with deliberate stimulation of the
trigger area (touching, rubbing) before, during, and after
administration of the drug. It was, however, considered
unjustifiable to activate deliberately trigger areas repeatedly
during the course of an injection to determine the precise
temporal relationship between the peripheral vascular effects
and relief of pain ; so this was not closely defined.
Results
8 patients were given tolazoline intravenously, and in
6 there was a dramatic cessation of attacks and inactiva-
tion of trigger areas, persisting for some hours ; but in 2
there was little definite change. In 5 of these patients
(3 responding and 2 resistant) further intravenous tests
were possible (after at least 48 hours’ interval) and gave
similar results. Of the 2 showing no remission with
intravenous therapy one was subsequently found to have
an acoustic neuroma and the other showed smaller peri-
pheral vascular responses than usual. The final case
in the series was treated only orally and went into a-
remission for 4 months.
Illustrative Case-reports
Case 1.&mdash;A woman, aged 66, with tic affecting the second
and third divisions of the right trigeminal nerve for 18 months.
She had had numerous increasingly severe attacks daily for
many weeks when first seen, most of them coming on spon-
taneously, trigger areas being inconstantly active. Her blood-
pressure was 190/90 mm. Hg. Oral tolazoline 25 mg. t.d.s.
produced subjective flushing and immediate reduction in the
number and severity of her attacks, and at higher dosage
(50 mg. t.d.s.) the attacks ceased entirely in 2 days, the
patient remaining pain-free under this regime for nearly a week.
At this point inert tablets were substituted, and the pains
promptly recurred, though not to their usual extent before
therapy. Restoration of oral tolazoline did not control these
pains as completely as before (nor was the flushing response
so definite) ; but a single 50-mg. intravenous dose produced
marked vascular responses and immediate complete freedom
lasting 3 days. Over the next 2 weeks limited pains reappeared
on three occasions, and on each 50 mg. intravenously produced
immediate relief lasting some days without further therapy.
The pains did not return after the final injection, and the
patient has remained pain-free for more than 2 years without
further treatment.
Case 2.-A woman, aged 52, with tic affecting the second
and third divisions of her right trigeminal nerve for 16 years,
treated 14 years previously by alcohol injection. She had
had, for 3 weeks, numerous severe attacks dail , triggered
consistently from gum and lip. Blood-pressure 140/80 mm. Hg.
Intravenous olazoline 25 mg. produced flushing and dramatic
relief of both spontaneous and provoked pains. Within 10
minutes food could be chewed on that side and dentures
inserted for the first time in 3 weeks, the trigger areas being
entirely inactive. However, 3 hours later slight tingling and
soreness could be provoked from the trigger areas, and within
12 hours the pains had returned to some extent. Surgical
intervention prevented further observations.
Case 3.-A woman, aged 51, with tic affecting the third
division of her right trigeminal nerve for 8 years, treated
on three occasions by alcohol injection. Numerous severe
attacks had been occurring daily for 3 weeks, and oral
trigger areas were acutely active. Blood-pressure 105/85 mm.
Hg. An oral test dose of tolazoline 12-5 mg. was given, but
the pains were so distressing that an intravenous injection
was started without awaiting the oral response. 10 mg. intra-
venously unfortunately produced " bumping 
" in the chest,
shivering, and numerous extra systoles, along with warming
of the extremities. However, the attacks ceased, and within
25 minutes of the injection the trigger areas became inactive,
and the face could be rubbed and food taken without incident
for the first time in 2 weeks. The cardiac abnormalities sub-
sided within 2 hours of the injection. Apart from one spon-
